Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.68 billion. The enterprise value is $2.52 billion.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SRPT has 98.28 million shares outstanding. The number of shares has increased by 0.83% in one year.
Current Share Class | 98.28M |
Shares Outstanding | 98.28M |
Shares Change (YoY) | +0.83% |
Shares Change (QoQ) | -10.24% |
Owned by Insiders (%) | 4.41% |
Owned by Institutions (%) | 91.06% |
Float | 93.86M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 14.73 |
PS Ratio | 0.89 |
Forward PS | 0.66 |
PB Ratio | 1.79 |
P/TBV Ratio | 1.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 0.64 |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.13 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 1.19.
Current Ratio | 4.02 |
Quick Ratio | 2.06 |
Debt / Equity | 1.19 |
Debt / EBITDA | 39.65 |
Debt / FCF | n/a |
Interest Coverage | -6.26 |
Financial Efficiency
Return on equity (ROE) is -23.61% and return on invested capital (ROIC) is -3.02%.
Return on Equity (ROE) | -23.61% |
Return on Assets (ROA) | -2.19% |
Return on Invested Capital (ROIC) | -3.02% |
Return on Capital Employed (ROCE) | -4.10% |
Revenue Per Employee | $1.63M |
Profits Per Employee | -$181,041 |
Employee Count | 1,372 |
Asset Turnover | 0.67 |
Inventory Turnover | 2.71 |
Taxes
In the past 12 months, SRPT has paid $84.20 million in taxes.
Income Tax | 84.20M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.10% in the last 52 weeks. The beta is 0.60, so SRPT's price volatility has been lower than the market average.
Beta (5Y) | 0.60 |
52-Week Price Change | -89.10% |
50-Day Moving Average | 40.46 |
200-Day Moving Average | 93.36 |
Relative Strength Index (RSI) | 18.51 |
Average Volume (20 Days) | 7,498,399 |
Short Selling Information
The latest short interest is 9.89 million, so 10.06% of the outstanding shares have been sold short.
Short Interest | 9.89M |
Short Previous Month | 9.26M |
Short % of Shares Out | 10.06% |
Short % of Float | 10.53% |
Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, SRPT had revenue of $2.23 billion and -$248.39 million in losses. Loss per share was -$2.59.
Revenue | 2.23B |
Gross Profit | 449.69M |
Operating Income | -117.21M |
Pretax Income | 62.22M |
Net Income | -248.39M |
EBITDA | -78.25M |
EBIT | -117.21M |
Loss Per Share | -$2.59 |
Full Income Statement Balance Sheet
The company has $522.76 million in cash and $1.36 billion in debt, giving a net cash position of -$833.96 million or -$8.49 per share.
Cash & Cash Equivalents | 522.76M |
Total Debt | 1.36B |
Net Cash | -833.96M |
Net Cash Per Share | -$8.49 |
Equity (Book Value) | 1.14B |
Book Value Per Share | 11.63 |
Working Capital | 1.83B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$547.15 million and capital expenditures -$148.16 million, giving a free cash flow of -$695.31 million.
Operating Cash Flow | -547.15M |
Capital Expenditures | -148.16M |
Free Cash Flow | -695.31M |
FCF Per Share | -$7.08 |
Full Cash Flow Statement Margins
Gross margin is 20.14%, with operating and profit margins of -5.25% and -11.12%.
Gross Margin | 20.14% |
Operating Margin | -5.25% |
Pretax Margin | -7.35% |
Profit Margin | -11.12% |
EBITDA Margin | -3.50% |
EBIT Margin | -5.25% |
FCF Margin | n/a |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.83% |
Shareholder Yield | -0.83% |
Earnings Yield | -14.77% |
FCF Yield | -41.35% |
Dividend Details Analyst Forecast
The average price target for SRPT is $64.00, which is 274.05% higher than the current price. The consensus rating is "Buy".
Price Target | $64.00 |
Price Target Difference | 274.05% |
Analyst Consensus | Buy |
Analyst Count | 25 |
Revenue Growth Forecast (5Y) | 11.55% |
EPS Growth Forecast (5Y) | 31.88% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 0.1666666:1.
Last Split Date | Jul 12, 2012 |
Split Type | Reverse |
Split Ratio | 0.1666666:1 |
Scores
SRPT has an Altman Z-Score of 2.33 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.33 |
Piotroski F-Score | 1 |